JP2016530890A5 - - Google Patents

Download PDF

Info

Publication number
JP2016530890A5
JP2016530890A5 JP2016542356A JP2016542356A JP2016530890A5 JP 2016530890 A5 JP2016530890 A5 JP 2016530890A5 JP 2016542356 A JP2016542356 A JP 2016542356A JP 2016542356 A JP2016542356 A JP 2016542356A JP 2016530890 A5 JP2016530890 A5 JP 2016530890A5
Authority
JP
Japan
Prior art keywords
medium
producing
cells
kit
process according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016542356A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016530890A (ja
JP6629210B2 (ja
Filing date
Publication date
Priority claimed from FR1358909A external-priority patent/FR3010720B1/fr
Application filed filed Critical
Publication of JP2016530890A publication Critical patent/JP2016530890A/ja
Publication of JP2016530890A5 publication Critical patent/JP2016530890A5/ja
Application granted granted Critical
Publication of JP6629210B2 publication Critical patent/JP6629210B2/ja
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016542356A 2013-09-16 2014-09-12 エンベロープウイルスの産生方法 Ceased JP6629210B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1358909A FR3010720B1 (fr) 2013-09-16 2013-09-16 Procede de production de virus enveloppes
FR1358909 2013-09-16
PCT/FR2014/052279 WO2015036713A1 (fr) 2013-09-16 2014-09-12 Procede de production de virus enveloppes

Publications (3)

Publication Number Publication Date
JP2016530890A JP2016530890A (ja) 2016-10-06
JP2016530890A5 true JP2016530890A5 (https=) 2017-10-19
JP6629210B2 JP6629210B2 (ja) 2020-01-15

Family

ID=50424334

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016542356A Ceased JP6629210B2 (ja) 2013-09-16 2014-09-12 エンベロープウイルスの産生方法

Country Status (11)

Country Link
US (1) US10125352B2 (https=)
EP (1) EP3047025B1 (https=)
JP (1) JP6629210B2 (https=)
CN (1) CN105722984B (https=)
CA (1) CA2923554C (https=)
DK (1) DK3047025T3 (https=)
ES (1) ES2732154T3 (https=)
FR (1) FR3010720B1 (https=)
RU (1) RU2016114541A (https=)
SG (1) SG11201602017YA (https=)
WO (1) WO2015036713A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3014901B1 (fr) 2013-12-17 2017-06-09 Genethon Procede de purification de virus ou vecteurs viraux enveloppes
EP3365453A2 (en) 2015-10-22 2018-08-29 Juno Therapeutics GmbH Methods, kits, agents and apparatuses for transduction
WO2021041322A1 (en) 2019-08-23 2021-03-04 Lonza Walkersville, Inc. Methods and constructs for production of lentiviral vector
AU2022212090A1 (en) 2021-01-28 2023-07-06 Allogene Therapeutics, Inc. Methods for transducing immune cells
WO2023114949A1 (en) * 2021-12-16 2023-06-22 Sana Biotechnology, Inc. Methods and systems of particle production

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101400379B1 (ko) 2004-11-05 2014-05-28 웰스테트 바이올로직스 코포레이션 안정하고 여과 가능한 외피보유 바이러스 조성물
US7875446B2 (en) 2006-04-20 2011-01-25 Wyeth Llc Purification processes for isolating purified vesicular stomatitis virus from cell culture
DK2307551T3 (en) 2008-06-18 2017-03-20 Oxford Biomedica (Uk) Ltd CLEANING RETROVIRAL VECTORS
ES2639307T3 (es) * 2011-06-30 2017-10-26 Genethon Péptidos con propiedades potenciadoras de infección vírica y su uso
US20140315294A1 (en) * 2011-11-24 2014-10-23 Genethon Scalable lentiviral vector production system compatible with industrial pharmaceutical applications
FR3014901B1 (fr) 2013-12-17 2017-06-09 Genethon Procede de purification de virus ou vecteurs viraux enveloppes

Similar Documents

Publication Publication Date Title
Bobadilla et al. Efficient transduction of myeloid cells by an HIV-1-derived lentiviral vector that packages the Vpx accessory protein
Munis Gene therapy applications of non-human lentiviral vectors
Negre et al. Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cells
Tomás et al. LentiPro26: novel stable cell lines for constitutive lentiviral vector production
Benskey et al. Lentivirus production and purification
Ikeda et al. Continuous high-titer HIV-1 vector production
Gao et al. The influenza A virus PB2, PA, NP, and M segments play a pivotal role during genome packaging
Kobayashi et al. Pseudotyped lentivirus vectors derived from simian immunodeficiency virus SIVagm with envelope glycoproteins from paramyxovirus
JP2016530890A5 (https=)
JP2018534937A5 (https=)
JP2016028035A5 (https=)
JP2021502799A (ja) レトロウイルスベクター
Kim et al. Stability of retroviral vectors against ultracentrifugation is determined by the viral internal core and envelope proteins used for pseudotyping
WO2019228117A1 (zh) 慢病毒载体及其递送外源rna的方法
JP2018516557A (ja) レンチウイルスベクターのバイオ生産法
Sinn et al. Lentiviral vectors pseudotyped with filoviral glycoproteins
Hermann et al. Mutations in gp120 contribute to the resistance of human immunodeficiency virus type 1 to membrane-anchored C-peptide maC46
JP2024028802A (ja) レンチウイルスパッケージングシステム、それにより製造されたレンチウイルス、及び、該レンチウイルスで形質導入された細胞、並びに、それを使用して宿主細胞のレンチウイルスの収率を向上させる方法
JP6629210B2 (ja) エンベロープウイルスの産生方法
King et al. Technical considerations for the generation of novel pseudotyped viruses
JPWO2020059848A1 (ja) レンチウイルスベクター産生の増強方法
Mautino et al. Improved titers of HIV-based lentiviral vectors using the SRV-1 constitutive transport element
Miskin et al. A replication competent lentivirus (RCL) assay for equine infectious anaemia virus (EIAV)-based lentiviral vectors
CN104262477A (zh) 一种禽CCCH型锌指蛋白chZAP及其应用
Kuate et al. Development and characterization of a minimal inducible packaging cell line for simian immunodeficiency virus‐based lentiviral vectors